YOLT-203
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for YOLT-203, covering 2025-03-24 to 2025-05-16. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1) [EARLY_Phase 1]